Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2000
11/16/2000WO2000068361A1 Versican and epithelial-mesenchymal interaction
11/16/2000WO2000068360A1 A histidine kinase, 636 hk, of staphylococcus aureus
11/16/2000WO2000068267A1 LOW-DOSE IL-1β-INDUCED PHOTORECEPTOR CELL RESCUE WITHOUT RETINAL DYSPLASIA
11/16/2000WO2000068266A1 Amyloid precursor protein protease and related nucleic acid compounds
11/16/2000WO2000068265A1 Antimicrobial theta defensins and methods of using same
11/16/2000WO2000068264A2 A peptide inhibitor of fibrinogen blood clotting
11/16/2000WO2000068263A2 Stereoselective antifibrillogenic peptides and peptidomimetics thereof
11/16/2000WO2000068258A2 Compounds exhibiting an antibiotic activity
11/16/2000WO2000068256A1 Cephaibols, novel antiparasitics from acremonium tubakii, method for the production and the utilization thereof
11/16/2000WO2000068255A2 Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application
11/16/2000WO2000068254A1 Spray drying of thrombin inhibitors
11/16/2000WO2000068251A1 Biological production of stable glutamine, poly-glutamine derivatives in transgenic organisms and their use for therapeutic purposes
11/16/2000WO2000068250A1 7tm receptor rat apj
11/16/2000WO2000068249A2 Novel g-protein modulator (gpm) proteins and nucleic acid molecules and uses therefor
11/16/2000WO2000068247A2 Serine proteases
11/16/2000WO2000068243A1 Methods using mechanisms of action of aroa
11/16/2000WO2000068240A1 NOVEL aroA
11/16/2000WO2000068185A1 A structure-based approach to design inhibitors of protein-processivity factor interactions
11/16/2000WO2000068140A1 Signal transduction response regulator family of staphylococcus
11/16/2000WO2000067803A1 Compositions and methods for improving learning and memory
11/16/2000WO2000067795A1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies
11/16/2000WO2000067793A1 Death domain containing receptor 4
11/16/2000WO2000067791A1 Ccr4 antagonists in sepsis
11/16/2000WO2000067790A1 Method for treating tnf-receptor type-2-induced diseases
11/16/2000WO2000067783A1 509hk
11/16/2000WO2000067782A2 Ceruloplasmin and an antioxidant composition comprising the same and their uses as neuroprotective agent
11/16/2000WO2000067781A1 Cardioprotective composition comprising ceruloplasmin and uses thereof
11/16/2000WO2000067780A1 Methods of modulating fabh activity
11/16/2000WO2000067778A1 Gonadotrophins
11/16/2000WO2000067777A1 A method of prophylaxis and treatment and agents useful therefor
11/16/2000WO2000067776A1 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
11/16/2000WO2000067775A1 Fibroblast growth factor 15
11/16/2000WO2000067774A2 Materials for soft tissue augmentation and methods of making and using same
11/16/2000WO2000067773A2 Combinations of immunosupressive agents for the treatment or prevention of graft rejections
11/16/2000WO2000067772A1 Galenic formulations of argatroban for subcutaneous administration
11/16/2000WO2000067771A1 Antiangiogenic endostatin peptides, endostatin variants and methods of use
11/16/2000WO2000067770A1 Treatment of acute myocardial infarction with a substance related to the growth hormone axis
11/16/2000WO2000067769A1 Enhanced survival of cancer patients treated with erythropoietin and antitumor agents
11/16/2000WO2000067763A1 Method of stimulating growth in aquatic animals using growth hormones
11/16/2000WO2000067762A2 Selenium-containing pro-drugs for cancer therapy
11/16/2000WO2000067761A1 Compositions and methods for identifying antigens which elicit an immune response
11/16/2000WO2000067739A2 Opioid antagonists containing compositions for enhancing analgesic potency of tramadol and attenuating its adverse side effects
11/16/2000WO2000067736A2 Therapeutic use of an inhibitor or an antagonist of an abc protein in bone
11/16/2000WO2000067728A2 Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
11/16/2000WO2000067700A2 Recombinant vaccine against botulinum neurotoxin
11/16/2000WO2000067575A1 0623hk
11/16/2000WO2000053633A3 Antibody and chemokine constructs that are directed to ccr5, and their use for treating autoimmune diseases
11/16/2000WO2000047223A3 Viral vaccine
11/16/2000WO2000043508A3 Cancer-associated proteins
11/16/2000WO2000042179A3 Complex-forming proteins
11/16/2000WO2000041717A3 Chorionic gonadotropin dna vaccines and methods
11/16/2000WO2000040273A3 Treatment of viral diseases using an interferon omega expressing polynucleotide
11/16/2000WO2000039287A3 A. fumigatus acetyl coenzyme-a carboxylase genes and polypeptides and uses thereof
11/16/2000WO2000039285A3 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof
11/16/2000WO2000039149A3 Secreted proteins and uses thereof
11/16/2000WO2000038665A3 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
11/16/2000WO2000038625A3 Facial tissue composition and method of use for sequestration of nasal secretion skin irritants
11/16/2000WO2000037639A3 Lymphocytic membrane proteins
11/16/2000WO2000037613A3 Human akt-3
11/16/2000WO2000037482A3 Peptides and peptide analogues designed from hfe protein and their uses in the treatment of iron overload diseases
11/16/2000WO2000036118A3 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE)
11/16/2000WO2000034468A3 Muc-1 antagonists and methods of treating immune disorders
11/16/2000WO2000034331A3 Analogues of glp-1
11/16/2000WO2000032765A3 Ribozyme therapy for the treatment and/or prevention of restenosis
11/16/2000WO2000029015A3 INFLUENCING OF ANGIGENESIS USING CD66a
11/16/2000WO2000029012A3 Methods of alleviating cancer symptoms
11/16/2000WO2000028032A3 Human cell surface receptor proteins
11/16/2000WO2000027377A3 Phosphinate peptide analogs for the treatment of fibrotic disorders
11/16/2000WO2000026247A3 Ikaros isoforms and mutants
11/16/2000WO2000025578A3 Methods for cloning animals
11/16/2000WO2000023466A3 Human rna binding proteins
11/16/2000WO2000023464A3 Zinc finger binding domains for gnn
11/16/2000WO2000020448A3 Nlk1 -interacting proteins
11/16/2000WO2000018365A3 Fast dissolving orally consumable films
11/16/2000WO2000014113A3 Method of stimulating prosaposin receptor activity
11/16/2000WO2000009549A3 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use
11/16/2000WO2000007631A9 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response
11/16/2000WO2000007543A8 Conjugates targeted to the interleukin-2 receptors
11/16/2000WO2000005375A9 Gbs toxin receptor
11/16/2000WO2000001713A3 Diacylglycerol acyl transferase proteins
11/16/2000DE19921887A1 Synergistic ectoparasiticide combination for use in human or veterinary medicine, comprising cyclic depsipeptide and piperazine compound as potentiating agent
11/16/2000DE19921346A1 Sprühtrocknung von Thrombininhibitoren Spray drying of thrombin inhibitors
11/16/2000DE19919149A1 Von Interferon alpha-2 abgeleitete Peptid-Homodimere und Peptid-Heterodimere Of interferon alpha-2 derived peptide homodimers and peptide heterodimers
11/16/2000DE19919148A1 Von Interleukin 12 abgeleitete Peptid-Homodimere und Peptid-Heterodimere Interleukin 12 derived peptide homodimers and peptide heterodimers
11/16/2000CA2388092A1 Stereoselective antifibrillogenic peptides and peptidomimetics thereof
11/16/2000CA2374237A1 Compositions and methods for identifying antigens which elicit an immune response
11/16/2000CA2373759A1 Serine proteases
11/16/2000CA2373618A1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies
11/16/2000CA2373617A1 Compositions and methods for improving learning and memory
11/16/2000CA2373348A1 Opioid antagonists containing compositions for enhancing analgesic potency of tramadol and attenuating its adverse side effects
11/16/2000CA2373182A1 A structure-based approach to design inhibitors of protein-processivity factor interactions
11/16/2000CA2373121A1 Vector-mediated delivery of integrating transposon sequences
11/16/2000CA2373068A1 Spray drying of thrombin inhibitors
11/16/2000CA2373063A1 Death domain containing receptor 4
11/16/2000CA2373058A1 Ceruloplasmin and an antioxidant composition comprising the same and their uses as neuroprotective agent
11/16/2000CA2373054A1 Cardioprotective composition comprising ceruloplasmin and uses thereof
11/16/2000CA2372881A1 Novel nucleic acids and proteins with p53 activity and altered tetramerization domains
11/16/2000CA2372871A1 Novel nucleic acids and proteins with growth hormone activity
11/16/2000CA2372821A1 Antimicrobial theta defensins and methods of using same
11/16/2000CA2372815A1 Extracellular matrix and adhesion-associated proteins
1 ... 2324 2325 2326 2327 2328 2329 2330 2331 2332 2333 2334 2335 2336 2337 2338 2339 2340 2341 2342 2343 2344 ... 3163